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Porcine mesenchymal stem cells in postnatal muscle have been demonstrated to differentiate into adipocytes. This increases 
adipocyte number and lipid accumulation, and is thought to be the origin of intramuscular fat. In this study, the effects of myo-
statin and arginine on adipogenic differentiation in mesenchymal stem cells derived from porcine muscle (pMDSCs) were in-
vestigated in vitro. Intracellular triglyceride levels were reduced by exogenous myostatin and increased by arginine supple-
mentation or myostatin antibody (P<0.01). The inhibition of lipid accumulation by myostatin in pMDSCs was alleviated by 
arginine supplementation (P<0.01). Expression patterns of adipogenic transcription factors showed that exogenous myostatin 
suppressed PPARγ2 and aP2 expression (P<0.01), while supplemental arginine or myostatin antibody promoted ADD1 ex-
pression (P<0.01). Furthermore, compared with the addition of either myostatin protein or antibody alone, ADD1 and PPARδ 
expression were promoted by the combination of arginine and myostatin (P<0.01), and arginine combined with myostatin an-
tibody promoted the expression of ADD1, PPAR, C/EBP, PPAR2 and LPL in pMDSCs (P<0.05). These results suggest that 
myostatin inhibits adipogenesis in pMDSCs, and that this can be alleviated by arginine supplementation, at least in part, 
through promoting ADD1 and PPAR expression. 
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Over the last few decades, the growth performance of do-
mestic animals has been improved by genetic selection, 
comfortable circumstances, and optimal nutrition, which has 
led to poor meat quality [1]. Intramuscular fat (IMF) is one 
of the main factors affecting meat quality, and has attracted 
increasing attention in animal production [2,3]. Adipose 
tissue is composed of numerous adipocytes containing large 
numbers of lipid droplets. The IMF content thus depends on 
the adipocyte number and lipid accumulation. Satellite cells 
or mesenchymal stem cells residing in postnatal muscle 
have been shown to differentiate into adipocytes [4–7], and 
are believed to be the source of IMF [8]. 
Arginine is an essential amino acid for pregnant sows 
and newborn piglets, and is required for fetal and neonatal 
growth and development [9–11]. Arginine supplementation 
has been reported to increase the IMF content of the longis-
simus dorsi, while decreasing carcass fat content in grow-
ing-finishing pigs [12]. It has been suggested that arginine 
modulates fat deposition in skeletal muscle and subcutane-
ous fat in different ways. Myostatin, also known as GDF-8, 
is a negative regulator of skeletal muscle growth and de-
velopment [13,14]. Myostatin was recently reported to in-
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hibit myogenesis and promote adipogenesis [15], and was 
able to substitute for dexamethasone in inducing adipogenic 
differentiation of mouse mesenchymal stem cells (MSCs) in 
vitro [16]. Nevertheless, inconsistent results have been re-
ported in primary human bone marrow MSCs [17]. Despite 
this, it has been suggested that myostatin is involved in fat 
deposition and modulation of adipogenic differentiation. 
Although the roles of myostatin in skeletal muscle growth 
regulation have been widely recognized, its effects on adi-
pogenic differentiation are poorly understood. In this study, 
we therefore focused on the effects of myostatin on adipo-
genesis in porcine-muscle-derived mesenchymal stem cells 
(pMDSCs), and the modulation of this activity by arginine. 
Furthermore, the involvement of several adipogenic tran-
scription factors, including ADD1, C/EBPα, PPARγ and 
PPARδ, was investigated to improve our understanding of 
the molecular mechanisms of the process. 
1  Materials and methods 
1.1  Animals 
Crossed Duroc×Landrace×Yorkshire (DLY) growing pigs 
weighing about 35 kg were used. The animals were housed 
in the Experimental Farm of Animal Nutrition Institute, 
Sichuan Agricultural University. All animal handling was 
conducted according to Institutional Guidelines after ac-
quiring permission from Sichuan Agricultural University 
Institutional Animal Care and Use Committee. 
1.2  Isolation and culture of pMDSCs 
pMDSCs were harvested as described previously [18], with 
modifications. Briefly, longissimus dorsi muscles were dis-
sected from DLY growing pigs and the vascular tissue and 
fascia were removed. Samples were washed three times in 
Hank’s balanced salt solution (HBSS), minced into small 
pieces and digested with 0.2% type II collagenase (Gibco, 
Grand Island, NY) at 37°C for 40–60 min. After digestion, 
suspensions were washed twice in HBSS and centrifuged at 
1500 r min1 for 5 min. Pellets were suspended in DMEM/ 
F12 (1:1) (Dulbecco’s Modified Eagle Media: Nutrient 
Mixture F-12 (1:1), Gibco) and passed through 40-µm cell 
strainers (Becton Dickinson) to yield single-cell suspen-
sions. 
Nucleated cells were centrifuged and resuspended in 
growth medium, DMEM/F12 (1:1) (Gibco) containing 10% 
fetal bovine serum (MSC qualified, Gibco), 100 U mL1 
penicillin and 100 g mL1 streptomycin (Gibco). Cells 
were plated in 35-mm tissue culture treated dishes (Corning, 
Lowell, MA) and incubated at 37°C. MSCs were isolated 
primarily based on their adhesion characteristics. Suspensions 
with nonadherent cells were transferred into 100-mm dishes 
or T75 tissue culture treated flasks (Corning) after 15 min 
incubation, to exclude contaminating macrophages, most of 
which would be attached to the culture dish. Cells were 
cultured at 37°C in a saturated humidity, 5% CO2 tis-
sue-culture incubator as passage 0. Forty-eight hours after 
initial plating, the cells were washed twice with HBSS to 
remove nonadherent cells, cultured in fresh growth medium, 
and half the medium was replaced every three days. Once 
the cells reached 70%–80% confluence, they were detached 
with 0.25% trypsin-0.038% EDTA (Gibco) and reseeded in 
fresh medium, as above. MSCs were extracted based on 
their adherent characteristics and purified during serial pas-
sages. 
The fibroblast-like spindle morphology of cells derived 
from porcine muscle was assessed under a microscope (Ax-
iosvert 2000 microscope equipped with AxioCam MRc 5 
camera and AxioVision Rel. 4.6 software; Carl Zeiss, Jena, 
Germany). For further characterization, the immunopheno-
type was determined by immunofluorescence histochemis-
try and fluorescence-activated cell sorting (FACS) using the 
antibodies described below. Multipotency of cells was con-
firmed by multiple-lineage induction and characterization of 
corresponding mesenchymal cells. Cells were expanded in 
culture up to eighth passage, and only early passage cells 
(passages 3–8) were used. 
1.3  Immunofluorescence with multiple labeling 
Cells were labeled and observed as previously described [19] 
with modifications. Exponentially-grown cells were washed 
twice with phosphate-buffered saline (PBS), fixed in 4% 
paraformaldehyde for 20 min and permeabilized in 0.5% 
Triton X-100 in PBS for 30 min with gentle rocking. After 
fixation and permeabilization, cells were rinsed (3×5 min) 
in PBS, blocked with 5% normal donkey serum in PBS for 
30 min, incubated with purified rat antibodies to porcine 
CD90 in PBS for 2 h, and incubated with fluorescein isothi-
ocyanate (FITC)-conjugated affinity-purified F(ab')2 frag-
ment donkey anti-rat IgG (H+L) (min×bovine, chicken, goat, 
guinea pig, Syrian hamster, horse, human, mouse, rabbit and 
sheep serum proteins) in PBS for 30 min. For multiple la-
beling, the above procedure was followed, and cells were 
incubated with purified mouse antibodies to porcine CD29, 
and incubated with rhodamine (TRITC)-conjugated affini-
ty-purified F(ab′)2 fragment donkey anti-mouse IgG (H+L) 
(min×bovine, chicken, goat, guinea pig, Syrian hamster, 
horse, human, rabbit, rat and sheep serum proteins) in PBS. 
Cells were nuclear stained with 4′,6-diamidino-2-pheny-        
lindole (DAPI) for 20 min. Thorough washing was per-
formed after each step, including after blocking. Glycerol 
50% in PBS was added to protect fluorescence followed by 
immediate visualization using an Axiosvert 2000 micro-
scope equipped with an AxioCam MRc 5 camera and Axio-
Vision Rel. 4.6 software (Carl Zeiss). Images were collected 
sequentially (ZVI files), converted to JPG files, and con-
trast-stretched without further processing. Rat monoclonal 
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IgG CD90 and mouse monoclonal IgG CD29 were used as 
primary antibodies (BD Biosciences), diluted at 1:100. 
Donkey anti-rat IgG conjugated with FITC or donkey an-
ti-mouse IgG conjugated with TRITC were used as second-
ary antibodies for immunofluorescence (multiple-labeling 
grade; Jackson Immunoresearch Laboratories, West Grove, 
PA), at 1:200 dilution. Negative control cells were incubat-
ed with mouse or rat IgG antibody (BD Biosciences) under 
the same conditions. 
1.4  Flow cytometry and phenotypic analysis 
Standard flow cytometry techniques were used to determine 
the cell surface epitope profile (CD31, CD34, CD45, CD29, 
CD49f, and CD90). Briefly, prior to antibody labeling, the 
cells were washed twice with PBS. Cells were incubated 
with purified mouse antibodies to porcine CD29 (BD Bio-
sciences) or CD45 (Santa Cruz Biotechnology, Delaware 
Avenue, CA) at 1:100 dilution for 30 min, then incubated 
with allophycocyanin (APC)-conjugated affinity-purified 
F(ab′)2 fragment donkey anti-mouse IgG (H+L) (min×bovine, 
chicken, goat, guinea pig, Syrian hamster, horse, human, 
rabbit, rat and sheep serum proteins) (multiple-labeling 
grade; Jackson Immunoresearch Laboratories) at a 1:200 
dilution in PBS. Cells were incubated with phycoerythrin 
(PE)-conjugated mouse monoclonal antibodies to porcine 
CD31 (BD Biosciences). After labeling with APC or PE, 
cells were incubated with FITC-conjugated rat monoclonal 
antibodies to porcine CD34, CD49f, or CD90 (all antibodies 
were purchased from BD Biosciences, San Diego, CA) for 
multiple labeling. The isotype (negative) controls used in 
this study were subjected to the same conditions to evaluate 
the levels of nonspecific binding. All cell suspensions were 
washed twice with PBS and resuspended in PBS for analy-
sis on a flow cytometer (FACSCalibur; BD Biosciences). At 
least 100000 labeled cells were collected and the data were 
analyzed using FCS Express Version 3.0 (De Novo Soft-
ware, Los Angeles, CA). 
1.5  Multilineage differentiation assays 
Cells were plated in growth medium at a density of 5×103 
cm2 for 48 h to reach 70%–80% confluency. For myogenic 
differentiation, cells were incubated in DMEM-LG (Dul-
becco’s Modified Eagle Media, low glucose, Gibco) sup-
plemented with 10 mol L1 5-azacytidine, 2% horse serum 
and antibiotics at 37°C for the initial 24-h period, then 
washed twice with PBS and maintained in the same condi-
tions without 5-azacytidine for up to four weeks. Desmin 
expressed in skeletal muscle plays an important role in 
skeletal muscle cell differentiation and was detected with 
purified mouse antibody to porcine desmin (Santa Cruz) and 
TRITC-conjugated donkey anti-mouse IgG (H+L) (Jackson 
Immunoresearch Laboratories) by immunohistochemistry, 
as described above, and multinucleated myotubes were ob-
served under a phase contrast microscope (Axiovert 2000, 
Carl Zeiss). For adipogenic differentiation, cells were incu-
bated in medium containing high-glucose DMEM 
(DMEM-HG) with 10% FBS (Gibco), 1 mol L1 dexame-
thasone, 10 mg L1 insulin, 0.5 mmol L1 3-isobutyl-1-        
methylxanthine, 100 mol L1 indomethacin, 100 U mL1 
penicillin and 100 g mL1 streptomycin (Gibco) (DIM). 
After 14 d induction, formation of lipid vacuoles in the cells 
was visualized by Oil Red O staining according to pub-
lished protocols [20]. For osteogenic differentiation, cells 
were cultured in low-glucose DMEM (DMEM-LG) sup-
plemented with 10% FBS (Gibco), 100 nmol L1 dexame-
thasone, 10 mmol L1 -glycerophosphate, 50 g L1 ascor-
bic acid, 100 U mL1 penicillin and 100 g mL1 strepto-
mycin (Gibco). On day 21, cultures were stained for alka-
line phosphatase using the calcium-cobalt method and ex-
tracellular matrix mineralization was assessed by von Kossa 
staining for four weeks. Medium was changed every 3–4 
days. All the reagents were from Sigma (Sigma, Saint Louis, 
MO), unless otherwise specified. 
1.6  Adipogenic differentiation and modulation 
Cells were plated in growth medium at a density of 5×103 
cm2 for 48 h to reach 70%–80% confluency. To exclude 
disturbances caused by the presence of arginine in the basal 
DMEM medium, arginine-deficient DMEM-HG was cus-
tomized and provided by Sunrise Science (San Diego, CA). 
Cells were exposed to either 50 g mL1 arginine (Sigma), 
100 ng mL1 recombinant myostatin (PeproTech, Rocky 
Hill, NJ), 4 g mL1 monoclonal rat antibody to human 
myostatin (R&D Systems, McKinley Place, NE), arginine 
combined with recombinant myostatin, or arginine combined 
with the monoclonal antibody to myostatin, in addition to 
DIM adipogenic induction medium. Negative and differentia-
tion control group cells were exposed to DMEM-HG (argi-
nine-deficient) supplemented with 10% FBS, 100 U mL1 
penicillin and 100 g mL1 streptomycin, or DIM, respec-
tively. Cells were cultured at 37°C, in a saturated humidity, 
5% CO2 tissue-culture incubator, and the medium was re-
placed with corresponding fresh medium every three days. 
The expression of adipogenic transcription factors on day 2, 
and the accumulation of intracellular triglycerides after 14 d 
induction were measured by real-time quantitative poly-
merase chain reaction (PCR) and fluorometric assay. 
1.7  Adipogenesis assay 
On day 14, intracellular triglyceride accumulation, in the 
form of lipid droplets, was determined using an Adipogene-
sis Assay Kit (BioVision, Mountain View, CA), according 
to the manufacturer’s instructions. This assay can detect 
triglycerides in 1000 differentiated adipocytes with high 
sensitivity. A fluorometric assay at excitation and emission 
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wavelengths of 535 and 587 nm, respectively, was per-
formed using a Varioskan Flash (Thermo Fisher Scientific, 
Waltham, MA). Protein concentrations were detected with 
BCA Protein Assay Reagent (Pierce, Rockford, IL) and the 
triglyceride content was corrected to protein content. 
1.8  RNA isolation and reverse transcription-PCR 
Total RNA was extracted from adherent cultured cells using 
RNAiso Plus reagent (Takara, Dalian, China), according to 
the manufacturer’s instructions. cDNA synthesis was per-
formed for 15 min at 37°C and 5 s at 85°C, using 2 μg total 
RNA as a template, 5×primer script, random 6-mer, primer 
script RT enzyme Mix, oligo dT primer (50 mol L1) 
(Takara). Total RNA and cDNA was stored at 70°C until 
use. 
1.9  Real-time quantitative PCR 
Real-time quantitative PCR was performed in a CFX96 Re-
al-Time System (Bio-Rad, Berkeley, CA) using SsoFast 
EvaGreen Supermix (Bio-Rad) in a final volume of 20 μL. 
The thermal cycling conditions were 95°C for 30 s followed 
by 40 cycles of 95°C for 10 s and 60–62°C for 10 s. Each 
primer pair designed with Primer 3.0 was blasted against 
expected published sequences to confirm specificity, and 
yielded a single peak in the melting curve and a single band 
of the expected size in agarose gel electrophoresis. The 
gene-specific primers used were synthesized by Invitrogen 
and are listed in Table 1. Standard curves were established 
to measure the amplification efficiency of all target and 
housekeeping genes, which ranged from 102.4% to 119.9%. 
The relative expression of the target gene was calculated 
using the formula 2(Ct), where Ct is the difference be-
tween the sample Ct and the control (untreated) Ct, Ct is 
the difference in Ct between the gene of interest and the 
geometric average of the reference genes, and Ct is the cycle 
at which the threshold is crossed. All samples were run at 
least in duplicate. Target gene expression was normalized to 
the commonly used reference genes, ACTB, GAPDH and 
18s rRNA, as described previously [21]. 
1.10  Statistical analyses 
Statistical analyses were performed using SAS software 
(Release 8.1; SAS Inst. Inc.). After confirming normal dis-
tribution on histograms, data were analyzed by one-way 
ANOVA using the generalized linear model procedure. Da-
ta were presented as mean±standard deviation. Differences 
among means were tested by the least significant difference 
method and P<0.05 was considered to be statistically sig-
nificant. 
Table 1  Primer pairs used for real-time quantitative PCRa) 
No. Gene name GenBank ID Primer sequence Product size Tm (°C) 












4 C/EBP AF103944 F: CGTGGAGACTCAACAGAAGG 95 60 
R: CGTGGAGACTCAACAGAAGG 
5 PPAR2 NM_214379.1 F:AATTAGATGACAGCGACCTGGCGA 102 60 R: TGTCTTGAATGTCCTCGATGGGCT 












9 PPAR NM214152.1 F: GCCTCCATCGTCAATAAG 166 60 
R: GAGCCAGGTCACTATCATC 








a) Abbreviations: ACTB, β-actin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; 18s rRNA, 18s ribosomal ribonucleic acid; PPARγ2, peroxisome 
proliferator-activated receptor γ2; LPL, lipoprotein lipase; aP2, fatty acid-binding protein adipocyte P2; ADD1, adipocyte determination and differentiation 
factor 1; C/EBPα, CCAAT/enhancer binding protein α; PPARδ, peroxisome proliferator-activated receptor δ; GATA-2, GATA binding protein 2; GATA-3, 
GATA binding protein 3; Tm, annealing temperature. 
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2  Results 
2.1  Characterization of adherent cells from porcine 
muscle 
Cells were characterized by their adherence to plastic and 
by their fibroblast-like spindle morphology. Adherent cells 
from porcine longissimus dorsi were initially heterogeneous 
(Figure 1A and B), but the cellular morphology became 
homogeneous during subculturing (Figure 1C and D). No 
abnormal morphology was noted up to passage 8. For fur-
ther characterization, the immunophenotype was determined 
by immunofluorescence histochemistry and FACS using the 
antibodies described. Their non-hematopoietic and non-en-     
dothelial origin (CD45-, CD31-, CD34-negative) (Figure 1I), 
MSC marker expression (CD29 and CD90) (Figure 1E–I) 
and their capabilities of differentiating into myoblasts (Fig-
ure 2A–D), preadipocytes (Figure 2E–H), and osteoblasts 
(Figure 2I–L) were confirmed. Their cellular morphology, 
expression of surface antigens, and multipotency all indi-
cated that the cells investigated in this study were pMDSCs. 
2.2  Adipogenesis assay 
As shown in Figure 3, compared with DMEM-HG (negative 
control), triglyceride levels were increased in cells after 14 
days adipogenic induction (P<0.01). Intracellular triglycer-
ide levels were reduced under adipogenic differentia-
tion-induction conditions (DIM) by myostatin protein in 
addition to DIM (P<0.01), and were increased by supple-
mental arginine or myostatin antibody. Lipid accumulation 
was not promoted by a combination of arginine and myo-
statin antibody, compared to cells exposed to myostatin 
antibody alone, but the inhibition of lipid accumulation in 
pMDSCs by myostatin was alleviated by arginine supple-
mentation (P<0.01). These results suggest that exogenous 
myostatin inhibited adipogenesis, but this effect could be 




Figure 1  Morphology and phenotypic characterization of pMDSCs. Cellular morphology of pMDSCs was observed by microscopy on day 3 (A), or at 
confluence phase at passage 0 (B), 1 (C), and 3 (D). Immunophenotype was determined by immunofluorescence histochemistry and flow cytometry. CD29 
(E) and CD90 (F) were stained with rhodamine (TRITC, red) or fluorescein isothiocyanate (FITC, green), respectively. Nucleoli (G) were stained with 
4',6-diamidino-2-phenylindole (DAPI, blue), and the confocal images (H) were merged with SPOT 4.6 software. At least 100000 labeled cells were collected  
and the data was analyzed with FCS Express Version 3.0 (De Novo Software) (I). 
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Figure 2  Multiple differentiation potentials of pMDSCs. A–D, Morphological changes and multinucleated myotube formation were observed under a 
microscope. Desmin expression was confirmed by immunofluorescence, and desmin was stained with rhodamine (TRITC, red) after 28 days of myogenic 
differentiation induction. E–H, Lipid accumulation after adipogenic induction was confirmed by Oil red O staining. Nucleoli were stained with 
4′,6-diamidino-2-phenylindole (DAPI, blue) and the confocal images (D and H) were merged with SPOT 4.6 software (I–L). The osteogenic phenotype of 
the cells was identified after four weeks of osteogenic induction. Compared with the controls (I and K), increasing alkaline phosphatase activity (J) and min- 
eralized matrix (L) were demonstrated by Ca-Co stain and von Kossa stain, respectively. 
 
Figure 3  Intracellular triglyceride contents of cells from porcine muscle 
after 14 days of adipogenic induction. DIM+Arg/MSTN/anti-MSTN, DIM 
medium supplemented with either 50 g mL1 arginine, 100 ng mL1 re-
combinant myostatin, or 4 g mL1 monoclonal antibody to myostatin; 
DIM+Arg+MSTN, DIM medium supplemented with 50 g mL1 arginine 
and 100 ng mL1 recombinant myostatin; DIM+Arg+anti-MSTN, DIM 
medium supplemented with 50 g mL1 arginine and 4 g mL1 monoclo-
nal antibody to myostatin. Error bars denote standard deviation (n=8). 
Different small letters represent significant difference at P<0.05, and dif- 
ferent large letters represent significant difference at P<0.01. 
2.3  Expression pattern of adipogenic transcription 
factors 
Adipogenic differentiation induction suppressed myostatin 
gene expression on day 2 (Figure 4). Exogenous addition of 
myostatin protein had no effect on endogenous myostatin 
gene expression in pMDSCs. However, supplemental argi-
nine or myostatin antibody increased myostatin gene ex-
pression (P>0.05) and significant promotion was detected in  
 
 
Figure 4  Myostatin gene expression in pMDSCs after 2 d adipogenic 
induction. Error bars denote standard deviation (n=6). Different small 
letters represent significant difference at P<0.05, and different large letters  
represent significant difference at P<0.01. 
cells treated with a combination of arginine and myostatin 
antibody (P<0.05). Regarding the adipogenic transcription 
factors, arginine supplementation promoted ADD1 expres-
sion (P<0.01) and increased C/EBP, PPAR and LPL 
(P>0.05) in pMDSCs. Exogenous myostatin protein sup-
pressed PPAR2 and aP2 expression (P<0.01), while myo-
statin antibody promoted ADD1 expression but suppressed 
PPAR2 and aP2 expression (P<0.05). Furthermore, ADD1 
and PPAR expression were promoted by a combination of 
arginine and myostatin, compared to myostatin alone 
(P<0.01), though no changes in PPAR2 and aP2 expres-
sion were observed. A combination of arginine and myo- 
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Table 2  Expression pattern of adipogenic transcriptional factorsa) 
Treatments C/EBP PPAR2 LPL aP2 ADD1 PPAR GATA-2 GATA-3 
DMEM-HG 1.00±0.08A 1.00±0.21A 1.08±0.25ABab 3.83±1.19Aa 1.00±0.11A 1.56±0.09A 1.30±0.10Aa 1.22±0.06 
DIM 1.26±0.15 6.69±2.18Cd 1.44±0.25Bbc 12.10±2.22Bc 1.24±0.14ABa 2.06±0.42AB 1.11±0.19 1.15±0.2 
DIM+Arg 1.42±0.16Bb 4.99±2.03BCcd 1.55±0.38Bc 11.66±4.07Bc 1.70±0.23C 2.33±0.34B 1.22±0.14ABabc 1.11±0.14 
DIM+MSTN 1.08±0.06a 2.25±0.92Aa 1.27±0.17B 4.08±2.01A 1.05±0.13A 2.31±0.64B 1.07±0.13cd 1.00±0.14 
DIM+anti-MSTN 1.09±0.09a 4.63±1.72BCbc 1.40±0.32Bbc 7.43±3.67b 1.53±0.19Bb 2.34±0.45B 1.00±0.20Bd 1.09±0.08 
DIM+Arg+MSTN 1.17±0.08 2.78±0.59ABab 1.00±0.13Aa 3.97±1.02Aa 1.59±0.21BCb 3.06±0.27C 1.10±0.10bd 1.20±0.11 
DIM+Arg+anti-MSTN 1.42±0.52Bb 6.85±2.16Cd 2.29±0.63C 9.34±4.65B 2.33±0.50D 3.35±0.57C 1.30±0.29Aab 1.30±0.37 
P-value 0.0093 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.0283 0.1720 
a) The results are shown as means±standard deviation, n=6. Different small letters following figures in the same column represent significant difference 
at P<0.05, and different capital letters following figures in the same column represent significant difference at P<0.01. 
 
 
statin antibody promoted the expression of ADD1, PPAR, 
C/EBP, PPAR2 and LPL in pMDSCs, compared to myo-
statin antibody alone (P<0.05). Unexpectedly, the results 
showed that adipogenic differentiation induction down-      
regulated GATA-2 and GATA-3 expression, and arginine 
and myostatin treatment had no obvious effects on their 
expression. These results suggest that myostatin suppressed 
PPAR2 and aP2 expression, and that this inhibition could 
be alleviated by arginine supplementation, at least in part, 
through promoting ADD1 and PPAR expression in 
pMDSCs. 
3  Discussion 
Although their precise identification remains a challenge [22], 
MSCs have been defined as being derived from mesenchymal 
tissue, with the functional capacities for self-renewal and 
multipotent differentiation [23]. In accord with several pre-
vious studies [24,25], the current study confirmed the mes-
enchymal nature (CD29-, CD90-positive expression) and 
non-hematopoietic, non-endothelial origin of the cells, 
based on their lack of cell surface expression of CD45, 
CD34 and CD31. The fibroblast-like spindle morphology, 
cell surface epitopes, and capacity for multilineage mesen-
chymal differentiation confirmed that the cells used in this 
study were pMDSCs. 
Animal growth performance has recently been improved 
by genetic selection, comfortable circumstances, and opti-
mal nutrition, though these advances have been at  the cost 
of meat quality [1]. IMF is one of the most important in-
dexes of meat quality, and is positively correlated with fac-
tors such as shearing force, tenderness, and flavor. At the 
cellular level, the IMF content depends on the adipocyte 
number and the lipid accumulation [26]. Satellite cells or 
MSCs residing in postnatal muscle can be induced to dif-
ferentiate into adipocytes [4–7], and are believed to be the 
origin of IMF. The differentiation of MSCs in skeletal mus-
cle into adipocytes leads to increased adipocyte number and 
lipid accumulation [8], and investigation into the modula-
tion of adipogenic differentiation of muscle-derived MSCs 
would therefore improve our understanding of the mecha-
nisms of IMF deposition, and allow the exploration of novel 
approaches to improving the IMF content. 
Myostatin is known as a negative regulator of skeletal 
muscle growth and development, and has recently been re-
ported to be involved in fat deposition and adipogenic dif-
ferentiation modulation [27,28]. However, the mechanisms 
whereby myostatin influences adipogenic differentiation are 
still poorly understood. At the molecular level, adipogenesis 
results from transcriptional remodeling leading to the acti-
vation of numerous genes, including PPAR2, C/EBP, LPL, 
and aP2 [16]. Several transcription factors act cooperatively 
and sequentially in this process [26]. At the early stage, ad-
ipogenic differentiation is switched on by activation of 
ADD1 and PPAR [29], and GATA-2 and GATA-3 have 
been identified as the molecular gatekeepers of that transi-
tion. When genes are defective or missing, preadipocytes 
turn into fat cells, and conversely, high expression levels 
lead cells to remain as preadipocytes, with little lipid accu-
mulation [3032]. This study therefore investigated several 
adipogenic transcription factors, to improve our under-
standing of the molecular mechanisms involved.  
Adipose tissue primarily develops around birth, but adi-
pose cell numbers can increase throughout life in response 
to nutritional changes [29]. Arginine is a conditionally es-
sential amino acid for pregnant and lactating sows and 
newborn piglets, and is important for the growth and de-
velopment of the fetus and neonate [9–11]. A high-fat diet 
and arginine supplementation were recently reported by 
Jobgen et al. to differentially regulate gene expression and 
affect energy-substrate oxidation, redox state, fat accretion, 
and adipocyte differentiation in adipose tissue, and a bene-
ficial effect of arginine on ameliorating diet-induced obesity 
in rats was demonstrated [33]. Dietary supplementation with 
arginine increased muscle gain and decreased subcutaneous 
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fat deposition in growing-finishing pigs, and, arginine en-
hanced longissimus dorsi muscle protein, glycogen, and fat 
contents by 4.8%, 42%, and 70%, respectively [12]. These 
results indicated that arginine inhibited subcutaneous fat but 
promoted IMF deposition. However, the modulation of IMF 
by arginine is still poorly understood. The current study 
confirmed the inhibition and promotion of adipogenesis in 
pMDSCs by myostatin and arginine, respectively, and indi-
cated that the inhibitory effect of myostatin on adipogenic 
differentiation could be alleviated by arginine supplementa-
tion. ADD1, C/EBP, PPAR, GATA-2 and GATA-3 ex-
pression in pMDSCs were up-regulated by adipogenic in-
duction, but arginine and myostatin treatment had no obvi-
ous effect on GATA-2 and GATA-3 expression. Our results 
suggest that myostatin inhibited adipogenesis by suppress-
ing PPAR2 and aP2 expression in pMDSCs, and that this 
inhibition could be alleviated by arginine supplementation, 
at least in part, through promoting ADD1 and PPAR ex-
pression. The promotion of adipogenesis in pMDSCs by 
arginine is in agreement with the results of Tan et al., who 
reported that dietary arginine supplementation increased the 
IMF content in growing-finishing pigs [12]. It seems para-
doxical that myostatin inhibited adipogenesis, while en-
dogenous myostatin expression was promoted by supple-
mental arginine in pMDSCs. Nevertheless, our results sug-
gest that myostatin protein and arginine had no significant 
effects on the numbers of adipogenic cells, and arginine 
exhibited limited effects on endogenous myostatin expres-
sion, suggesting that the modulation of adipogenesis by 
arginine could not be attributed to endogenous myostatin 
expression. Further investigations are needed to clarify the 
molecular mechanisms responsible for the effects of myo-
statin and arginine on adipogenesis, and to identify novel 
ways of improving the IMF content in animal production. 
In conclusion, the results of this study indicate that adi-
pogenesis is inhibited by the addition of myostatin, and that 
arginine promotes adipogenic differentiation in pMDSCs. 
The inhibitory effect of myostatin on adipogenic differenti-
ation can be alleviated by arginine supplementation, at least 
partially through up-regulation of ADD1 and PPAR ex-
pression. 
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